These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 33357065)
1. Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment. Zhao Z; Liu W Technol Cancer Res Treat; 2020; 19():1533033820962117. PubMed ID: 33357065 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695 [TBL] [Abstract][Full Text] [Related]
3. Role of the microbiome in occurrence, development and treatment of pancreatic cancer. Wang Y; Yang G; You L; Yang J; Feng M; Qiu J; Zhao F; Liu Y; Cao Z; Zheng L; Zhang T; Zhao Y Mol Cancer; 2019 Dec; 18(1):173. PubMed ID: 31785619 [TBL] [Abstract][Full Text] [Related]
4. The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer. Martinez-Useros J; Garcia-Foncillas J Biomed Res Int; 2016; 2016():1869304. PubMed ID: 28078281 [TBL] [Abstract][Full Text] [Related]
5. Application of glycoscience to the early detection of pancreatic cancer. Miyoshi E; Kamada Y Cancer Sci; 2016 Oct; 107(10):1357-1362. PubMed ID: 27418030 [TBL] [Abstract][Full Text] [Related]
7. Research progress on circularRNAs in pancreatic cancer: emerging but promising. Wang YZ; An Y; Li BQ; Lu J; Guo JC Cancer Biol Ther; 2019; 20(9):1163-1171. PubMed ID: 31138014 [TBL] [Abstract][Full Text] [Related]
14. Early detection markers in Pancreas Cancer. Farrell JJ; van Rijnsoever M; Elsaleh H Cancer Biomark; 2005; 1(2-3):157-75. PubMed ID: 17192037 [TBL] [Abstract][Full Text] [Related]
15. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786 [TBL] [Abstract][Full Text] [Related]
16. Screening for pancreatic cancer in familial high-risk individuals: A systematic review. Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410 [TBL] [Abstract][Full Text] [Related]
17. Biochemical diagnostics of pancreatic cancer - Present and future. Jelski W; Mroczko B Clin Chim Acta; 2019 Nov; 498():47-51. PubMed ID: 31430440 [TBL] [Abstract][Full Text] [Related]
18. [Precancerous conditions and risk factors for pancreatic and bile duct cancer]. Novotný I Klin Onkol; 2013; 26 Suppl():S29-33. PubMed ID: 24325160 [TBL] [Abstract][Full Text] [Related]
19. Molecular detection of pancreatic neoplasia: Current status and future promise. Majumder S; Chari ST; Ahlquist DA World J Gastroenterol; 2015 Oct; 21(40):11387-95. PubMed ID: 26526068 [TBL] [Abstract][Full Text] [Related]
20. Limitations in improving detection of pancreatic adenocarcinoma. Mendieta Zerón H; García Flores JR; Romero Prieto ML Future Oncol; 2009 Jun; 5(5):657-68. PubMed ID: 19519205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]